Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 20 August, 2010 and appeared in  Cardiovascular HealthIssue 535

Elevated Resting Heart Rate, Mortality Risk

An elevated resting heart rate that develops or persists during follow-up is associated with a significantly increased risk of death whether from heart disease or other causes, according to a study. Findings suggest patients and their doctors should track heart rate over time to uncover health issues… 

Advertisement

Researchers from the Ronald O. Perelman Heart Institute at New York-Presbyterian Hospital/Weill Cornell Medical Center found after studying outcomes in more than 9,000 patients, an elevated resting heart rate that develops or persists during follow-up is associated with a significantly increased risk of death, whether from heart disease or other causes.

The findings, suggest that tracking heart rate over time can provide a profoundly simple and important marker of health issues that could become lethal but which also might be prevented with diagnosis and treatment.

"It is easy and inexpensive to determine heart rate, and in fact is done routinely in a doctor's office. But this study suggests that physicians need to track the pattern over a number of years, not just consider single readings," says the study's lead investigator, Dr. Peter Okin, a noted cardiologist at the Ronald O. Perelman Heart Institute of New York-Presbyterian/Weill Cornell and professor of medicine in the Division of Cardiology at Weill Cornell Medical College.

"Based on this study, we believe that an elevated heart rate seen over a number of years is worrisome, signifying that these patients need further evaluation to see what might be causing the high heart rate," he says.

In their study, researchers discovered that development of a heart rate of 84 beats per minute or greater that either developed or persisted in patients during the study's average five-year time span was linked to a 55 percent greater risk of cardiovascular death and a 79 percent greater risk of death from all causes. Although the participants had hypertension, the scientists adjusted for this fact as well as for other cardiovascular risk factors. A healthy heart rate is between 60 and 80 beats per minute.

Even incremental increases in heart rate were associated with increased risk of death. For example, every extra 10 beats per minute higher than a normal resting pulse was associated with a 16 percent increased risk of death from cardiovascular disease and a 25 percent greater risk of all-cause death.

This is one of the few studies that has looked at changes in heart rate over time, says Dr. Okin. The notion is that because heart rates may increase or decrease over time in response to changes in a person's condition or response to a treatment, the predictive value of a single heart rate measurement is less valuable than measurements over time.

"Heart rates can change day to day and year to year," he says. "It's like having a higher body temperature one day that goes away the next. Something caused the fever, but it has resolved, perhaps with treatment. Heart rate is the same over a longer time span. If it goes up and remains elevated, some disorder is likely to blame."

For example, high heart rate, among other things, is a marker of increased sympathetic nervous system activity, which itself is linked to increased heart ischemia, and is also associated with promoting atherosclerosis and susceptibility to arrhythmia.

This study is a sub-analysis of the LIFE (Losartan Intervention For Endpoint) study, which has been completed. It enrolled 9,193 patients from Scandinavia and the United States to test two different treatments (losartan versus atenolol) for hypertension. Among other variables, heart rate was routinely measured in these patients.

In this study, researchers divided 9,190 patients into two groups -- those that had a persistent heartbeat rate of 84 or greater per minute, and those that had less. That figure was selected because other studies had suggested it was linked to mortality risk.

After a mean of almost five years, 814 patients (8.9%) died -- 438 (4.8%) from cardiovascular disease. After adjusting for possible effects of randomized treatment, and for every other risk factor (such as age, gender, race, diabetes, history of heart disease, and so on), the researchers found a strong association between persistent elevated heart rate and risk of death.

The patients died from a variety of causes, but considering all factors, "heart rate remains a significant predictor of increased mortality," Dr. Okin says. "In addition to high blood pressure, this study demonstrated that changing heart rate over time is a highly significant predictor of mortality."

To date, no medication has been approved in the United States that can reduce heart rate without side effects, although a drug (ivabradine) is being tested, he says. Exercise and diet have also been shown to lower heart rate.

European Heart Journal online July 2, 2010

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 20 August, 2010 and appeared in  Cardiovascular HealthIssue 535

Past five issues: Issue 628 | Diabetes Clinical Mastery Series Issue 86 | Issue 627 | Diabetes Clinical Mastery Series Issue 85 | Issue 626 |

2012 Most Popular Articles:

Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Two New Weight Loss Drugs Approved by FDA Advisory Committee
Posted May 18, 2012
New System Automatically Updates Weekly Insulin Dosage for Better Glycemic Control with Fewer Hypoglycemic Events
Posted May 18, 2012
Keep Your Waist Circumference to Less than Half Your Height
Posted May 18, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Insulin for DKA - Not Always a Good Choice!
Posted May 21, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
The Virtual Examination Room: How New Technology Can Improve Diabetes Care
Posted May 25, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
Glycemic Control Versus Brain Volume
Posted May 10, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
What other chronic conditions do your patients have?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control